No / channels that are critical for their development and function. Many ion channels contribute to T cell-mediated autoimmune and/or inflammatory responses, so they are attractive targets for pharmacological immune modulations. In this study, we conduct patch clamp experiments to exam the whole cell currents from lymphocytes after nanoparticles exposure with the aim to test if nanoparticles exposure brings any electrophysiological changes for lymphocytes, and to compare the electrophysiological responses of lymphocytes to drugs in nanoparticles forms. Our result suggests a potential inhibition of effects of IBU N on lymphocytes. Such cytotoxicity of nanoparticles in Lymphocytes may be mainly associated with the early membrane damage. These results are also mirrored by the DNA damages occurred on lymphocytes after exposure of nanoparticles. Further detailed investigation is needed to explain the changes of Lymphocytes in response to NPs in real time and dose differences. This would provide useful information in the evaluation of toxicology of nanoparticles and in understanding the underlying mechanism of their effects on ion channels in health and diseases.

I detta projektarbete skulle tre olika ölsorters beska bestämmas. Beskan skulle bestämmas analytiskt genom två metoder, en HPCL och en spektrofotometrisk. Det skulle även avgöras vilken av metoderna som lämpade sig bäst för detta. Ölsorter är ur Lundabryggeriets sortiment.  Beska mäts i IBU som är en förkortning på ”international bitterness units” och är milligram iso-α–syror per liter öl. Den analytiska IBU bestämningen skulle göras för att kunna få en uppskattning om hur riktiga de IBU värden var som Lundabryggeriet tidigare beräknat fram med hjälp ut av ett program, Glenn Tinseths.    De två olika analysmetoderna som användes var, en spektrofotometrisk metod ”Hope bitterness in beer” och en HPLC metod ” Iso α-, α-and β-acid in hope and isomerized hop extracts in beer”.   Under arbetets gång fastställdes det att tillredningen av extraktionslösningarna i den spektrofotometriska metoden är väldigt beroende på hur länge dessa lösningar skakas. Det fastställdes också att desto mörkare ölet var desto viktigare blev skakningstiden.    För HPLC metoden fastställdes det att lösligheten av substansen ICE-I3, i standarden, beror på polariteten i lösningsmedlet och att det inte är optimalt att använda svagt försurad metanol, som var angivet i metoden ”Iso α-, α-and β-acid in hope and isomerized hop extracts in beer”. Då metanolen är svagt försurad är den även mer polär, vilket resulterade i att ICE-I3 inte kunde lösas. Att använda metanol som inte var försurad visade sig vara mycket mer lämpligt.    I detta fall kunde det konstateras att den spektrofotometriska metoden var mer osäker än HPLC, speciellt då skakningstiden för fullständig extraktion av de isomerade syrorna inte kunde fastställas. Därför anses det vara bättre lämpat att fokusera på HPLC metoden vid fortsatt arbete för att fastställa ölsorternas IBU. / In this project, the bitterness of three different kinds of beers was to be determined. The bitterness would analytically be determined with two methods, a HPLC method and a spectrophotometric method. The aim of the project was also to decide whitch of the methods that was best suited for this determination.   Bitterness is measured in IBU which is an abbreviation of “International Bitterness Units” and is measured in milligram iso-α-acids per liter of beer. The analytical determination of the IBU was to be made, in order to get an estimate of how accurate previous entered IBU values were. Those values were estimated using calculations in the program, Glenn Tinseths.    The determination of the IBU was executed with two different methods of analysis, a spectrophotometric method “Hope bitterness in beer” and a HPLC method “Iso α-, α- and β-acid in Hope and isomerized hop extracts in beer”.    During the work it was concluded that the preparation of the extraction in the spectrophotometric method is very dependent on how long the solvents are shaken. It was also concluded that, the darker the beer was the more important the time of shaking the solvents was.    For the HPLC method, it was determined that the solubility of substance ICE I3, in the standard, depends on the polarity of the solvent and that it is not optimal to use low acidified methanol, which was specified by the method “Iso α-, α-and β-acid in Hope and isomerized hop extracts in beer”. When methanol is weakly acidfied, it is also more polar, resulting in that the ICE-I3 could not be resolved. Using methanol that was not acidified at all was shown to be more appropriate.    Finally, it was determined that the spectrophotometric method was more uncertain than the HPLC, especially when the specific time of shaking the solvents for complete extraction of the isomerade acids, could not be determined. The HPLC method is therefore considered to be the better fit of the two, and should be focus in further work of determining the beers IBU.

International Telemetering Conference Proceedings / October 23-26, 2000 / Town & Country Hotel and Conference Center, San Diego, California / The Tracking and Data Relay Satellite System (TDRSS) Multiple Access (MA) Return Service provides a communication path that originates at a customer platform (either a spacecraft or other type of emitter) and is routed through a geosynchronous Tracking and Data Relay Satellite (TDRS) back to a customer control center or data acquisition location. Conventional operations provide Space Network (SN) customers with MA Service based on a schedule generated from user requests. The MA Service currently provides return link telemetry services to customer platforms with real-time, playback, and science data rates up to 100 kbps. This paper describes an integrated approach, using state-of-the-art technology and fault-tolerant architecture, to develop the next generation of TDRSS MA beamforming equipment. New designs will result in significant reduction in beamformer size and cost by at least an order of magnitude relative to the current MA equipment. This new equipment will provide the potential for increased usage of TDRSS MA services. The paper describes the in-development Demand Access (DA) Return Service that provides a new class of service using next generation technology.

This diploma thesis discusses about technology of beer hopping. The first part describes beer history, beer brewing, hops and hop products. The second part deals with the practical beer brewing using different hop technologies. Seven different beers were brewed using the same dose of the same hops and one using the hop extract. IBU values were determined by calculation and spectrophotometer. A sensory analysis of the resulting beers was also carried out. It has been proven that different beer hopping technologies have shown a positive change in the resulting bitterness of beer. The best taste was the beer brewed with shortened hoping.

Advanced drug delivery systems have shown immense success through nanotechnology which overcomes the challenges posed by large sized particles such as poor solubility, bioavailability, absorption, and target-specific delivery. This study focuses on nano sizing by application of microreactor technology and nanoparticles to obtain polymeric particulate with a selection of model drugs for inhalation drug delivery routes. The development of nanoparticles of two challenging compounds in terms of solubility and permeability, namely Ibuprofen (IBU) and Salmeterol (SAL), was conducted using a continuous, controlled, and scalable system offered by microfluidic reactor with the incorporation of anti-solvent approach. The research explores the potential of this technology to enhance absorption rate and hence bioavailability of IBU via oral route, and SAL via inhalation. IBU, an anti-inflammatory drug, is classified as BCS Class II drug with low solubility and high permeability. SAL is a selective long acting β2-agonist which is co-dispensed along with a short-acting β2-agonist for quick relief of acute bronchoconstriction due to its long onset of action. This lack of the ‘kick’ effect in SAL can be attributed to its relatively higher lipophilicity which causes a delay in the diffusion to the β2 receptors on the smooth muscles. It is therefore feasible to assume that increasing the dissolution and/or diffusion rate of SAL in the interstitial fluids would reduce the delay between administration and the onset of action of this drug which would be beneficial to patients. Process and formulation parameters were investigated to optimize the production and stability of nano particles of both drugs using Y shaped microfluidic reactors. IBU results show that the smaller the angle between the two inlets were the smaller the particle size achieved. Moreover, the particle size increased with increasing the concentration of IBU solution. The effect of the polymer mixture ratio (PVP/HPMC) on the initial particle size was not clear though. The smallest particle size (113 nm) was achieved using 10° Y shaped chip with IBU concentration of 1 mg/mL and a polymer mixture of 0.3% w/v PVP and 0.5% w/v HPMC. Using a polymer mixture of 0.5% w/v of each polymer though yielded a better PDI (140nm and PDI of 0.5). Same observations were noted when the syringe pumps were replaced with a non-pulsatile pressure pump. Particle size though dropped significantly to 33nm. Stability data showed that all systems were practically stable regardless of the process or formulation parameters. In addition, a considerable 2.5 fold increase in dissolution rate was observed in the first 20 minutes when compared to the raw material. The optimized parameters were applied to SAL to produce nanocrystals with best result (59 nm) were obtained using 50µg/mL Salmeterol with microfluidics inlet angle 10° with non-pulse syringe pump. The stabilizing mixture was PVP 0.8% w/v and Tween 80 at a concentration of 0.02%. This approach offered a basis for the generation of nano sized SAL particles with higher fine particle fraction and better deposition in NGI than currently marketed formulations, thus providing a more efficient drug dose delivery and lung deposition.

The objective of this study was to develop a new method for co-crystal preparation which adhered to green chemistry principles, and provided advantages over conventional methods. A novel, solvent-free, high-power ultrasound (US) technique, for preparing co-crystals from binary systems, was chosen as the technology which could fulfil these aims. The application of this technology for solid state co-crystal preparation was explored for ibuprofen-nicotinamide (IBU-NIC), carbamazepine-nicotinamide (CBZ-NIC) and carbamazepine-saccharin (CBZ-SAC) co-crystals. The effect of different additives and processing parameters such as power level, temperature and sonication time on co-crystallisation was investigated. Characterisation was carried out using DSC, PXRD, FTIR, Raman and HPLC. In addition, an NIR prediction model was developed and combined with multivariate analysis (PLS) and chemometric pre-treatments. It was found to be a robust, reliable and rapid method for the determination of co-crystal purity for the IBU-NIC and CBZ-NIC pairs. Co-crystal quantification of US samples helped to optimise the US method. Finally, a model formulation of paracetamol containing 5% and 10% PEG 8000 was ultrasonicated at maximum power with different exposure times. A comparison of technological and physicochemical properties of the resulting tablets with those of the tablets obtained using the pressing method evidenced significant differences. This suggested that US energy dissipation (mechanical and thermal effects) was the main mechanism which caused the PAR form I tabletability to improve. It was found that the ultrasound–compacted tablets released the drug at a slower rate compared to pure PAR. This technique was shown to be useful for improving tabletability for low-compressible drugs without the need to use a conventional tabletting machine.

The objective of this study was to develop a new method for co-crystal preparation which adhered to green chemistry principles, and provided advantages over conventional methods. A novel, solvent-free, high-power ultrasound (US) technique, for preparing co-crystals from binary systems, was chosen as the technology which could fulfil these aims. The application of this technology for solid state co-crystal preparation was explored for ibuprofen-nicotinamide (IBU-NIC), carbamazepine-nicotinamide (CBZ-NIC) and carbamazepine-saccharin (CBZ-SAC) co-crystals. The effect of different additives and processing parameters such as power level, temperature and sonication time on co-crystallisation was investigated. Characterisation was carried out using DSC, PXRD, FTIR, Raman and HPLC. In addition, an NIR prediction model was developed and combined with multivariate analysis (PLS) and chemometric pre-treatments. It was found to be a robust, reliable and rapid method for the determination of co-crystal purity for the IBU-NIC and CBZ-NIC pairs. Co-crystal quantification of US samples helped to optimise the US method. Finally, a model formulation of paracetamol containing 5% and 10% PEG 8000 was ultrasonicated at maximum power with different exposure times. A comparison of technological and physicochemical properties of the resulting tablets with those of the tablets obtained using the pressing method evidenced significant differences. This suggested that US energy dissipation (mechanical and thermal effects) was the main mechanism which caused the PAR form I tabletability to improve. It was found that the ultrasound–compacted tablets released the drug at a slower rate compared to pure PAR. This technique was shown to be useful for improving tabletability for low-compressible drugs without the need to use a conventional tabletting machine.